This national analysis, spanning 5 y of data, demonstrated that 3% of adult trauma patients received early UMT. Although mortality was higher for those receiving UMT, 29% survived hospitalization. Notable survival was also observed in patients receiving > 100 units of pRBCs. Thus, the decision to continue or terminate massive transfusion protocol should involve multidisciplinary discussions among trauma providers and be tailored to individual patients, factoring in history, injuries, and resource availability.
Lu et al. (Fri,) studied this question.